|
|
|
| |
|
|
| |
The latest pharmaceutical manufacturing news from News Medical |
|
|
|
| |
 Achieve accurate, traceable medical gas verification
As medical gas standards and documentation requirements become increasingly rigorous, manufacturers need confidence in their verification processes. The Medical Gas Resource Pack offers practical guidance on quality control, oxygen verification, and medical gas systems to support compliant, reliable production while safeguarding product quality and patient safety.
Read all about how this gas analysis supports Medical Gas verification.
| |
|
|
|  | | | | |  S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial material for S2N’s first-in-human study in Australia. | |  | | | | |  Stem cell therapies may need new protein quality control standards Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle size, concentration, markers, morphology, contaminants, endotoxin, and assays. | |
|
|
|  | | |  Drug shortages pose a critical challenge to healthcare. Innovations in supply chain management are key to ensuring consistent access to essential medicines. | | | | |  Hot-melt extrusion supports the production of subcutaneous implants for contraception, chronic disease, and sustained drug delivery. | | | | |  Zylidac Bio, a fully integrated biologics CDMO within the Zydus Lifesciences Limited (Zydus) group, and Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering breakthrough yields, superior on-target quality, and precise process control, today announced a partnership to scale Prolific's platform from early development through GMP production. | | | | |  Lythrum salicaria extract supplementation led to body fat reduction in a clinical trial, suggesting a promising plant-based approach to weight management. | |
|
|
| | | How would you rate today's newsletter?
| |
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|
